Viatris Issues €650M Senior Notes Due 2033 at 4.250%

Viatris Inc. completed an underwriting agreement to issue €650 million in senior notes due 2033 with a 4.250% coupon, guaranteed by Mylan Inc. and subsidiaries. The debt offering provides capital for the pharmaceutical company and is underwritten by major investment banks including BNP Paribas, Citigroup, and Goldman Sachs.